$MZTI

Viso Luis (Strategic Advisor to CEO) sold 997 shares of MARZETTI CO (MZTI) at $100.81 ($0.10M total) on 2026-09-10.

Several food production stocks fell due to U.S. cattle shortages and rising livestock costs. Tyson Foods cut its 2026 outlook, citing beef-segment losses. Affected companies include Lamb Weston (LW, -3.4%), Kraft Heinz (KHC, -3.1%), Darling Ingredients (DAR, -3.3%), The Marzetti Company (MZTI, -4.3%), and Pilgrim's Pride (PPC, -2.5%).

Marzetti (MZTI) reported a 2.2% sales decline to $465.0M in Q4, but adjusted sales grew. Fiscal 2026 saw record net sales, gross profit, and operating income. Gross margin expanded 220 bps to 24.5%. A Cyclospora outbreak may cut Q1 sales by 250 bps, leading to a 15% drop in operating income. The company acquired Bachan's, which added $15.4M in sales.

Marzetti (MZTI) reported Q4 2026 net sales of $465M, down 2.2% YoY. Adjusted net sales rose 0.4%, driven by a 0.9% increase in retail sales, including $15.4M from Bachan's. Gross profit and operating income reached record highs, up 7.4% and 48.2% respectively. The company also reported record annual operating cash flow of $283.8M. The company increased its dividend by 5% and completed $36.3M in share buybacks.

The Marzetti Company (MZTI) has increased its dividend for 63 consecutive years, with the latest quarterly dividend at $1.00 per share. Fiscal 2026 saw record operating cash flow of $283.8 million, with dividends consuming 38% of it. Net income rose to $191.6 million, and gross margin expanded to 24.5%. The company rebranded in 2025, aligning with its food brands.

The London Company's Q2 2026 investor letter highlights The Marzetti Company (MZTI), a specialty food manufacturer. MZTI's stock closed at $112.53, with a 5.30% monthly return and a 38.37% 52-week decline. The company has a $3.071B market cap. The London Company attributes MZTI's recent decline to weaker retail volumes but expects margin expansion and growth from acquisitions and product launches.

The Marzetti Company (MZTI) reported Q2 CY2026 sales of $465M, down 2.2% YoY, missing expectations. Non-GAAP EPS of $1.46 beat estimates by 4.1%. Management cited lower sales volumes and the exit of a supply agreement for the decline, but attributed higher margins to productivity initiatives and the Bachan’s acquisition. The company expects growth from Bachan’s integration, new products, and pricing actions.

The Marzetti Co (MZTI) reported a 2.2% decline in Q4 net sales due to reduced club channel sales and pipeline build comparisons. A Cyclospora outbreak is expected to cause a 250 basis point net sales headwind in Q1 2027. Core retail business, excluding Bachan's, saw a 7% organic volume decline. Commodity inflation is forecasted at 5% for fiscal 2027. The company expects 100 basis points of gross margin growth in fiscal 2027, driven by Bachan's integration and cost savings. CEO Dave Ciesinski ant

The Marzetti Company (MZTI) reported Q2 CY2026 sales of $465M, down 2.2% YoY, missing estimates. Non-GAAP EPS of $1.46 beat expectations by 4.1%. Analysts project 7% revenue growth over the next 12 months, above sector average.

MARZETTI CO (MZTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SYMBOL: MZTI August 25, 2026 TRADED: Nasdaq THE MARZETTI COMPANY REPORTS FOURTH QUARTER AND FISCAL YEAR RESULTS WESTERVILLE , Ohio, August 25 - The Marzetti Company (Nasdaq: MZTI) reported results today for the company’s fiscal fourth quarter an